Table 1.
Characteristics of the population used for the validation analysis
| Sex n (%) | |
| Female | 39 (24.2) |
| Male | 122 (75.8) |
| Age (years) | |
| Mean ± SD (n, range) | 49.0 ± 9.8 (161, 25–77) |
| Median | 49.0 |
| Transmission route, n (%) | |
| Men having sex with men | 60 (37.3) |
| Intravenous drug users | 26 (16.1) |
| Heterosexual | 69 (42.9) |
| Other | 6 (3.7) |
| HIV status, n (%) | |
| Asymptomatic (CDC A) | 91 (56.5) |
| Symptomatic (CDC B | 47 (29.2) |
| AIDS (CDC C) | 23 (14.3) |
| Time from HIV diagnosis (years) | |
| Mean ± SD (n, range) | 13.4 ± 9.2 (160, 0–30) |
| Median | 13.5 |
| CD4 (cells/mm3) | |
| Mean ± SD (n, range) | 652 ± 312 (161, 24–1686) |
| Median | 611 |
| HIV-RNA cp/ml (log10) | |
| Mean ± SD (n, range) | 1.76 ± 0.6 (161, 1–6) |
| Median | 1.60 |